SALT Holding’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7M Hold
93,250
– – 9.37% 3
2026
Q1
$18.4M Hold
93,250
– – 11.11% 3
2025
Q4
$17.1M Buy
93,250
+84,650
+984% +$14.8M 13.29% 3
2025
Q3
$1.32M Buy
+8,600
New +$1.3M 1.23% 9
2025
Q2
– Sell
-7,600
Closed -$1.12M – 9
2025
Q1
$1.12M Hold
7,600
– – 1.04% 7
2024
Q4
$996K Buy
+7,600
New +$1.06M 1.22% 8

Other funds holding AZN

SALT Holding's AZN Position: Q2 2026 in Review

SALT Holding held its AstraZeneca (AZN) position steady in Q2 2026 at 93,250 shares worth $17.7M. The position accounts for 9.37% of the portfolio, ranked #3.

SALT Holding first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. The position peaked at $18.4M in Q1 2026. 1,513 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • SALT Holding held 93,250 shares of AstraZeneca worth $17.7M as of Q2 2026.
  • SALT Holding left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 9.37% of SALT Holding's portfolio in Q2 2026, its #3 holding.
  • SALT Holding first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
  • SALT Holding's AstraZeneca position peaked at $18.4M in Q1 2026.
  • 1,513 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on SALT Holding's 13F filing for Q2 2026, filed 14 Aug 2026.